22 related articles for article (PubMed ID: 1301403)
1. Neuroprotective effects of acetyl-L-carnitine on neuropathic pain and apoptosis: a role for the nicotinic receptor.
Di Cesare Mannelli L; Ghelardini C; Calvani M; Nicolai R; Mosconi L; Toscano A; Pacini A; Bartolini A
J Neurosci Res; 2009 Jan; 87(1):200-7. PubMed ID: 18709658
[TBL] [Abstract][Full Text] [Related]
2. Telmisartan inhibits hyperalgesia and inflammatory progression in a diabetic neuropathic pain model of Wistar rats.
Al-Rejaie SS; Abuohashish HM; Ahmed MM; Arrejaie AS; Aleisa AM; AlSharari SD
Neurosciences (Riyadh); 2015 Apr; 20(2):115-23. PubMed ID: 25864063
[TBL] [Abstract][Full Text] [Related]
3. Prevention of paclitaxel-evoked painful peripheral neuropathy by acetyl-L-carnitine: effects on axonal mitochondria, sensory nerve fiber terminal arbors, and cutaneous Langerhans cells.
Jin HW; Flatters SJ; Xiao WH; Mulhern HL; Bennett GJ
Exp Neurol; 2008 Mar; 210(1):229-37. PubMed ID: 18078936
[TBL] [Abstract][Full Text] [Related]
4. Altered neuroexcitability in experimental diabetic neuropathy: effect of acetyl-L-carnitine.
Malone JI; Lowitt S; Corsico N; Orfalian Z
Int J Clin Pharmacol Res; 1992; 12(5-6):237-41. PubMed ID: 1301404
[TBL] [Abstract][Full Text] [Related]
5. Acetyl-L-carnitine prevents substance P loss in the sciatic nerve and lumbar spinal cord of diabetic animals.
Di Giulio AM; Gorio A; Bertelli A; Mantegazza P; Ferraris L; Ramacci MT
Int J Clin Pharmacol Res; 1992; 12(5-6):243-6. PubMed ID: 1284499
[TBL] [Abstract][Full Text] [Related]
6. Preventive and curative effect of edaravone on nerve functions and oxidative stress in experimental diabetic neuropathy.
Saini AK; Kumar H S A; Sharma SS
Eur J Pharmacol; 2007 Jul; 568(1-3):164-72. PubMed ID: 17521626
[TBL] [Abstract][Full Text] [Related]
7. Morphological and electrophysiological changes of peripheral nerve-muscle unit in the aged rat prevented by levocarnitine acetyl.
Scarfò C; Falcinelli M; Pacifici L; Bellucci A; Reda E; De Angelis C; Ramacci MT; Angelucci L
Int J Clin Pharmacol Res; 1992; 12(5-6):253-62. PubMed ID: 1301406
[TBL] [Abstract][Full Text] [Related]
8. Effects of trolox on nerve dysfunction, thermal hyperalgesia and oxidative stress in experimental diabetic neuropathy.
Sharma SS; Sayyed SG
Clin Exp Pharmacol Physiol; 2006 Nov; 33(11):1022-8. PubMed ID: 17042909
[TBL] [Abstract][Full Text] [Related]
9. Counteraction on experimentally induced diabetic neuropathy by levocarnitine acetyl.
Pacifici L; Bellucci A; Piovesan P; Maccari F; Gorio A; Ramacci MT
Int J Clin Pharmacol Res; 1992; 12(5-6):231-6. PubMed ID: 1301403
[TBL] [Abstract][Full Text] [Related]
10. Acetyl-L-carnitine in diabetic polyneuropathy: experimental and clinical data.
Sima AA
CNS Drugs; 2007; 21 Suppl 1():13-23; discussion 45-6. PubMed ID: 17696589
[TBL] [Abstract][Full Text] [Related]
11.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
12.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
13.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
14.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
15.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]